Signal Transduction and Targeted Therapy (May 2022)
PROTAC mediated FKBP12 degradation enhances Hepcidin expression via BMP signaling without immunosuppression activity
Abstract
No abstracts available.
Signal Transduction and Targeted Therapy (May 2022)